This company has been acquired
Transphorm Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Transphorm has a total shareholder equity of $18.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $32.7M and $14.4M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$7.95m |
| Eşitlik | US$18.25m |
| Toplam yükümlülükler | US$14.41m |
| Toplam varlıklar | US$32.66m |
Son finansal sağlık güncellemeleri
Recent updates
Transphorm: Deal Likely Done Even If Not Everyone Is Happy
Feb 07Revenues Tell The Story For Transphorm, Inc. (NASDAQ:TGAN)
May 17
Transphorm, Inc. (NASDAQ:TGAN) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 17Transphorm bags ARPA-E contract for four-quadrant GaN switches
Aug 30Transphorm Non-GAAP EPS of -$0.08 in-line, revenue of $5.2M misses by $0.03M
Aug 15Transphorm: Turning Technology Into Revenue
Jul 28Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: TGAN's short term assets ($21.0M) exceed its short term liabilities ($12.4M).
Uzun Vadeli Yükümlülükler: TGAN's short term assets ($21.0M) exceed its long term liabilities ($2.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: TGAN is debt free.
Borcun Azaltılması: TGAN currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: TGAN has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: TGAN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.4% each year